Search company, investor...

Stage

Seed | Alive

Total Raised

$5.12M

About Wingit

Wingit finds out what's going on. Improvise with friends: Find real time events nearby, Buy last minute tickets, Book the closest uber cab and more.

Headquarters Location

La Gaité Lyrique - Créatis 3 bis rue Papin

Paris, 75003,

France

Loading...

Loading...

Wingit Patents

Wingit has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/29/2013

9/27/2016

Textile closures, Engine technology, Microfluidics, Lathes, Actuators

Grant

Application Date

3/29/2013

Grant Date

9/27/2016

Title

Related Topics

Textile closures, Engine technology, Microfluidics, Lathes, Actuators

Status

Grant

Latest Wingit News

Reflow Medical Announces Enrollment Completion in the WingIT IDE CTO Clinical Trial

Apr 10, 2019

Eighty-five patients with advanced peripheral artery disease enrolled in the Wing-IT trial were evaluated at 12 centers in the U.S., Germany, and Austria. John R. Laird, MD, of Adventist Heart and Vascular Institute, St. Helena, California, is the principal investigator for the study. “We would like to express our gratitude to the participating patients, physician investigators, research staff and employees. Their efforts have made it possible for us to reach this major milestone,” said Dr. Laird. The Wingman Crossing Catheter uses an extendable beveled tip that creates a channel to help penetrate, or cross, the occlusion. This enables further treatment of the lesion with therapeutic devices. Isa Rizk, Chief Executive Officer of Reflow Medical, commented, “Our goal is to expand the physician’s ability to treat CTOs, which often develop in patients with advanced peripheral artery disease. Facilitating CTO crossings helps physicians avoid amputations or bypass surgery , which directly correlates to better long-term outcomes.” About Reflow Medical, Inc. Reflow Medical, Inc. is a private company focused on empowering physicians through the design and development of innovative and effective technologies for cardiovascular disease. Reflow is developing a family of products to treat cardiovascular disease. View source version on businesswire.com: https://www.businesswire.com/news/home/20190410005156/en/ Jennifer Carlyle

Wingit Frequently Asked Questions (FAQ)

  • Where is Wingit's headquarters?

    Wingit's headquarters is located at La Gaité Lyrique - Créatis, Paris.

  • What is Wingit's latest funding round?

    Wingit's latest funding round is Seed.

  • How much did Wingit raise?

    Wingit raised a total of $5.12M.

  • Who are the investors of Wingit?

    Investors of Wingit include The Refiners, 5M Ventures, Grenoble Angels, Business Angels Switzerland and Rhone-Alpes Creation.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.